South Korea
· Delayed Price · Currency is KRW REYON Pharmaceutical Statistics
Total Valuation
KRX:102460 has a market cap or net worth of KRW 209.45 billion. The enterprise value is 406.32 billion.
| Market Cap | 209.45B |
| Enterprise Value | 406.32B |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:102460 has 18.34 million shares outstanding. The number of shares has decreased by -0.80% in one year.
| Current Share Class | 18.34M |
| Shares Outstanding | 18.34M |
| Shares Change (YoY) | -0.80% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 81.15% |
| Owned by Institutions (%) | 3.73% |
| Float | 2.96M |
Valuation Ratios
The trailing PE ratio is 51.90.
| PE Ratio | 51.90 |
| Forward PE | n/a |
| PS Ratio | 1.41 |
| PB Ratio | 0.84 |
| P/TBV Ratio | 0.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 99.66 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 137.28, with an EV/FCF ratio of -31.75.
| EV / Earnings | 100.55 |
| EV / Sales | 2.74 |
| EV / EBITDA | 137.28 |
| EV / EBIT | n/a |
| EV / FCF | -31.75 |
Financial Position
The company has a current ratio of 0.68, with a Debt / Equity ratio of 0.82.
| Current Ratio | 0.68 |
| Quick Ratio | 0.35 |
| Debt / Equity | 0.82 |
| Debt / EBITDA | 28.40 |
| Debt / FCF | -16.07 |
| Interest Coverage | -1.34 |
Financial Efficiency
Return on equity (ROE) is 1.63% and return on invested capital (ROIC) is -0.81%.
| Return on Equity (ROE) | 1.63% |
| Return on Assets (ROA) | -0.76% |
| Return on Invested Capital (ROIC) | -0.81% |
| Return on Capital Employed (ROCE) | -1.65% |
| Revenue Per Employee | 330.45M |
| Profits Per Employee | 9.02M |
| Employee Count | 448 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 2.08 |
Taxes
In the past 12 months, KRX:102460 has paid 1.03 billion in taxes.
| Income Tax | 1.03B |
| Effective Tax Rate | 20.31% |
Stock Price Statistics
The stock price has decreased by -15.84% in the last 52 weeks. The beta is 0.68, so KRX:102460's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | -15.84% |
| 50-Day Moving Average | 10,981.40 |
| 200-Day Moving Average | 12,908.75 |
| Relative Strength Index (RSI) | 59.40 |
| Average Volume (20 Days) | 33,880 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:102460 had revenue of KRW 148.04 billion and earned 4.04 billion in profits. Earnings per share was 220.05.
| Revenue | 148.04B |
| Gross Profit | 66.68B |
| Operating Income | -5.98B |
| Pretax Income | 5.07B |
| Net Income | 4.04B |
| EBITDA | 7.24B |
| EBIT | -5.98B |
| Earnings Per Share (EPS) | 220.05 |
Balance Sheet
The company has 8.82 billion in cash and 205.68 billion in debt, giving a net cash position of -196.87 billion or -10,733.73 per share.
| Cash & Cash Equivalents | 8.82B |
| Total Debt | 205.68B |
| Net Cash | -196.87B |
| Net Cash Per Share | -10,733.73 |
| Equity (Book Value) | 250.08B |
| Book Value Per Share | 13,635.27 |
| Working Capital | -41.20B |
Cash Flow
In the last 12 months, operating cash flow was 2.10 billion and capital expenditures -14.90 billion, giving a free cash flow of -12.80 billion.
| Operating Cash Flow | 2.10B |
| Capital Expenditures | -14.90B |
| Free Cash Flow | -12.80B |
| FCF Per Share | -697.86 |
Margins
Gross margin is 45.04%, with operating and profit margins of -4.04% and 2.73%.
| Gross Margin | 45.04% |
| Operating Margin | -4.04% |
| Pretax Margin | 3.43% |
| Profit Margin | 2.73% |
| EBITDA Margin | 4.89% |
| EBIT Margin | -4.04% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 1.31%.
| Dividend Per Share | 150.00 |
| Dividend Yield | 1.31% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 68.08% |
| Buyback Yield | 0.80% |
| Shareholder Yield | 2.11% |
| Earnings Yield | 1.93% |
| FCF Yield | -6.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 29, 2020. It was a forward split with a ratio of 1.02.
| Last Split Date | Dec 29, 2020 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
KRX:102460 has an Altman Z-Score of 1.38 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.38 |
| Piotroski F-Score | 3 |